Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Leyden Labs has raised $45.4M in total funding. The most recent round was Undisclosed. The last funding was announced in June 2026.
Leyden Labs's investors include European Investment Bank, Qiming Venture Partners, Bill & Melinda Gates Foundation, Invest-NL, Polaris Partners.
Leyden Labs is headquartered in Amsterdam, The Netherlands.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Leyden Labs is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leyden Labs — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/leyden-labs. Accessed October 29, 2026.
VCBacked. (2026). Leyden Labs — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/leyden-labs
{{cite web |title=Leyden Labs — Funding & Investors |url=https://www.vcbacked.co/company/leyden-labs |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated